Skip Navigation

Prostate CancerProstate Cancer Multidisciplinary Clinics

Men laughing advance to content
 

Care for Men Newly Diagnosed with Prostate Cancer

Top specialists in prostate cancer from multiple disciplines work together in the diagnosis and treatment of prostate cancer. During clinic you will receive a comprehensive assessment including:

  • Clinical evaluation
  • Expert review of all pathologic and radiographic studies
  • Recommendations for potential treatment plans; along with access to clinical trials and Johns Hopkins’ unparalleled care.

  • Locations

    Johns Hopkins offers clinics in Baltimore and Washington, D.C.

  • Prostate Cancer Experts

    Our clinics provide multidisciplinary teams of prostate cancer experts to treat your condition.

  • Your Initial Consultation

    Learn what to expect, eligibility criteria and information you need to provide to the care team.

 
  
 

Request An Appointment

To maintain patient and staff safety during COVID-19, consultations are only provided via Telemedicine, a video conferencing service with the medical team. Contact us to determine your eligibility for this service.
 
The Johns Hopkins Hospital
Sibley Memorial Hospital
Kayala Holliday, Operations Manager
 
 

Prostate Cancer Treatment and Radiation

 

Using the Latest Technology and Techniques in Prostate Radiation

The latest techniques in prostate radiation treatment are currently at Sibley. Learn about how technology and clinical trials are helping to improve care.

Treating Prostate Cancer with Radiation Therapy - Dr Daniel Song

Daniel Song, M.D., co-director of the Prostate Cancer Multidisciplinary Clinic at the Johns Hopkins Kimmel Cancer Center, explains the benefits of radiation treatment for patients diagnosed with prostate cancer.

Consultation for Prostate Cancer

Whether your prostate cancer diagnosis is low or high risk, your consultation provides you with the most appropriate treatment option. As a leading expert in prostate cancer care, we provide you with the latest advancements in treatment, including access to clinical trials.

Eligibility Criteria

  • Localized low, intermediate or high-risk prostate cancer (Gleason 3+4 or higher), untreated
  • Locally advanced (lymph node positive) prostate cancer, untreated
  • Biochemically recurrent prostate cancer after local therapy (prostatectomy, radiotherapy) with rising PSA level
  • Oligometastatic prostate cancer (5 or fewer metastases)

What you need before your visit

  • All medical records about your diagnosis
  • Pathology slides
  • CD of bone scan and CT/MRI of abdomen and pelvis only if:
    • PSA level is greater than 20, or
    • Gleason score of 8, 9, or 10
  • Insurance and demographic information

Prostate Cancer Experts

Learn more about the Johns Hopkins multidisciplinary prostate cancer team.

Locations

 
back to top button